High SULF1 mRNA expression in a tumor is associated with poor PFI in early stage patients (HR = 2.327, p = 0.023, Figure 3A) but not in late-stage patients (HR = 1.034, p = 0.842). This evidence concerns the gene SULF1 and neoplasm.